Leucine degradation in cell-free extracts of skeletal muscle
- 15 February 1979
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 178 (2) , 475-489
- https://doi.org/10.1042/bj1780475
Abstract
Since skeletal muscle is the major site in the body for oxidation of leucine, isoleucine and valine, the pathway and control of leucine oxidation were investigated in cell-free preparations of rat muscle. Leucine was found to be transaminated to 4-methyl-2-oxopentanoate, which was then oxidatively decarboxylated. On differential centrifugation 70–80% of the transaminase activity was recovered in the soluble fraction of the cell, and the remaining amount in the mitochondrial fraction. The transaminase, from both fractions had similar pH optima and both were markedly inhibited by Ca2+. Thus changes in cellular Ca2+ concentration may regulate transaminase activity. Both transaminases had a much higher affinity for 2-oxoglutarate than for pyruvate. Therefore the utilization of amino groups from leucine for the biosynthesis of alanine in muscle [Odessey, Khairallah & Goldberg (1974) J. Biol. Chem. 249, 7623–7629] in vivo involves transamination with 2-oxoglutarate to produce glutamate, which is then transaminated with pyruvate to produce alanine. The dehydrogenase activity assayed by the decarboxylation of methyl-2-oxo[1-14C]pentanoate was localized exclusively in the fraction containing mitochondria and required NAD+, CoA and thiamin pyrophosphate for optimal activity. Measurements of competitive inhibition suggested that the oxo acids of leucine, isoleucine and valine are all decarboxylated by the same enzyme. The enzyme activity was decreased by 90% upon freezing or sonication and was stimulated severalfold by Mg2+, K+ and phosphate ions. In addition, it was markedly inhibited by ATP, but not by non-metabolizable analogues. This observation suggests that splitting of ATP is required for inhibition. The oxidative decarboxylation of 4-methyl-2-oxopentanoate by the dehydrogenase appears to be the rate-limiting step for leucine oxidation in muscle homogenates and also in intact tissues. In fact, rat muscles incubated with [1-14C]leucine release 1-14C-labelled oxo acid into the medium at rates comparable with the rate of decarboxylation. Intact muscles also released the oxo acids of [1-14C]valine or [1-14C]isoleucine, but not of other amino acids. These findings suggest that muscle is the primary source of the branched-chain oxo acids found in the blood.This publication has 51 references indexed in Scilit:
- Calcium and muscle contractionPublished by Elsevier ,2003
- Regulation of pyruvate dehydrogenase kinase and phosphatase by acetyl-CoA/CoA and NADH/NAD ratiosBiochemical and Biophysical Research Communications, 1975
- Monovalent cation requirement for ADP inhibition of pyruvate dehydrogenase kinaseBiochemical and Biophysical Research Communications, 1974
- Hydroxamic acids I: Factors affecting the stability of the hydroxamic acid-iron complexJournal of Pharmaceutical Sciences, 1969
- Transaminase of branched chain amino acids II. Physiological change in enzyme activity in rat liver and kidneyBiochemical and Biophysical Research Communications, 1967
- The Statistical Analysis of Enzyme Kinetic DataPublished by Wiley ,1967
- The dependence of contraction and relaxation of muscle fibres from the crab Maia squinado on the internal concentration of free calcium ionsBiochimica et Biophysica Acta (BBA) - Specialized Section on Biophysical Subjects, 1964
- Tissue distribution of branched chain ketoacid decarboxylaseBiochimica et Biophysica Acta, 1961
- Metabolism of the white blood cells in maple-syrup-urine diseaseBiochimica et Biophysica Acta, 1960
- Localization of Interaction Sites in Multi-Component Transfer Systems: Theorems Derived from AnaloguesNature, 1958